Free tool
Healthcare stocks
We cover 1,006 companies in the Healthcare sector. The median market value in the group is $265.79M, measured across the 1,000 largest of them. Among those 1,000, the median move over the past trading day is −0.35%. 52% of the 961 with a 200-day average trade above it. Price change over the past year runs from −75.7% to +177.6% across the middle 80 percent of the group, with a median of 0.0%. Among those 1,000, 5 companies currently carry a tier A volume signal.
Other lists in this group
Table
1,006 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| R1DY34.SA | Dr. Reddy's Laboratories Limited | $9.95B | Mid cap | −20.54% |
| PODD | Insulet Corporation | $9.94B | Mid cap | −57.12% |
| AVTR | Avantor, Inc. | $9.81B | Mid cap | +9.93% |
| PTGX | Protagonist Therapeutics, Inc. | $9.80B | Mid cap | +146.62% |
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +62.83% |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.77B | Mid cap | +47.78% |
| OSCR | Oscar Health, Inc. | $9.55B | Mid cap | +83.55% |
| TWST | Twist Bioscience Corporation | $9.41B | Mid cap | +451.89% |
| PCVX | Vaxcyte, Inc. | $9.09B | Mid cap | +99.97% |
| IMVT | Immunovant, Inc. | $9.07B | Mid cap | +189.13% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −9.65% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% |
| HQY | HealthEquity, Inc. | $8.75B | Mid cap | +18.69% |
| BRKR | Bruker Corporation | $8.69B | Mid cap | +70.56% |
| ATR | AptarGroup, Inc. | $8.60B | Mid cap | −1.89% |
| TGTX | TG Therapeutics, Inc. Common Stock | $8.42B | Mid cap | +92.61% |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% |
| ALKS | Alkermes plc | $8.25B | Mid cap | +68.07% |
| SYRE | Spyre Therapeutics, Inc. | $8.13B | Mid cap | +446.12% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +9.35% |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +74.18% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +56.66% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% |
| PACS | PACS Group, Inc. | $7.03B | Mid cap | +274.28% |
| HIMS | Hims & Hers Health, Inc. | $6.96B | Mid cap | −32.22% |
| CGON | CG Oncology, Inc. | $6.95B | Mid cap | +196.15% |
| ERAS | Erasca, Inc. | $6.70B | Mid cap | +1112.03% |
| E2XE34.SA | Exelixis, Inc. | $6.61B | Mid cap | +23.92% |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +77.38% |
| ORKA | Oruka Therapeutics, Inc. | $6.58B | Mid cap | +555.07% |
| RADL3.SA | Raia Drogasil S.A. | $6.56B | Mid cap | +7.42% |
| COGT | Cogent Biosciences, Inc. | $6.39B | Mid cap | +196.85% |
| BLTE | Belite Bio, Inc | $6.31B | Mid cap | +144.07% |
| LQDA | Liquidia Corporation | $6.31B | Mid cap | +154.86% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | Mid cap | +143.24% |
| AMRX | Amneal Pharmaceuticals, Inc. | $6.27B | Mid cap | +92.20% |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% |
| XENE | Xenon Pharmaceuticals Inc. | $6.18B | Mid cap | +64.11% |
| BLCO.TO | Bausch + Lomb Corporation | $6.18B | Mid cap | +19.34% |
| BLCO | Bausch + Lomb Corporation | $6.16B | Mid cap | +18.56% |
| DNTH | Dianthus Therapeutics, Inc. | $6.13B | Mid cap | +356.93% |
| STVN | Stevanato Group S.p.A. | $6.11B | Mid cap | −0.09% |
| PTCT | PTC Therapeutics, Inc. Common Stock | $6.07B | Mid cap | +46.02% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.05B | Mid cap | +133.47% |
| RDNT | RadNet, Inc. | $6.05B | Mid cap | +7.27% |
| T1FX34.SA | Teleflex Incorporated | $6.00B | Mid cap | +0.29% |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +31.96% |
| DFTX | Definium Therapeutics, Inc. | $5.88B | Mid cap | +344.37% |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% |
| LGND | Ligand Pharmaceuticals Incorporated | $5.74B | Mid cap | +80.92% |
| CRSP | CRISPR Therapeutics AG | $5.73B | Mid cap | +10.65% |
| SHC | Sotera Health Company | $5.58B | Mid cap | +18.42% |
| MMED | MiniMed Group, Inc. | $5.48B | Mid cap | +5.41% |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | −0.28% |
| GRFS | Grifols, S.A. | $5.38B | Mid cap | −19.39% |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.07B | Mid cap | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +93.26% |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% |
| EWTX | Edgewise Therapeutics, Inc. | $4.80B | Mid cap | +207.13% |
| LFST | LifeStance Health Group, Inc. | $4.69B | Mid cap | +121.31% |
| CELC | Celcuity Inc. | $4.65B | Mid cap | +90.31% |
| WAY | Waystar Holding Corp. | $4.63B | Mid cap | −34.97% |
| BLLN | BillionToOne, Inc. | $4.54B | Mid cap | −11.68% |
| ICUI | ICU Medical, Inc. | $4.49B | Mid cap | +41.83% |
| NVST | Envista Holdings Corporation | $4.47B | Mid cap | +30.89% |
| ELVN | Enliven Therapeutics, Inc. | $4.46B | Mid cap | +194.32% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% |
| DOCS | Doximity, Inc. | $4.41B | Mid cap | −63.61% |
| LIVN | LivaNova PLC | $4.41B | Mid cap | +41.56% |
| MANE | Veradermics, Incorporated | $4.29B | Mid cap | +172.32% |
| TNGX | Tango Therapeutics, Inc. | $4.29B | Mid cap | +269.13% |
| RLAY | Relay Therapeutics, Inc. | $4.26B | Mid cap | +445.10% |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% |
| INDV | Indivior Pharmaceuticals, Inc. | $4.23B | Mid cap | +47.06% |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.13B | Mid cap | +292.38% |
| IRTC | iRhythm Holdings, Inc. | $4.06B | Mid cap | −29.83% |
| LEGN | Legend Biotech Corporation | $4.02B | Mid cap | −40.44% |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% |
| VKTX | Viking Therapeutics, Inc. | $4.01B | Mid cap | +29.15% |
| DNLI | Denali Therapeutics Inc. | $3.98B | Mid cap | +57.50% |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +55.97% |
| TLX | Telix Pharmaceuticals Limited | $3.77B | Mid cap | −8.02% |
| IOVA | Iovance Biotherapeutics, Inc. | $3.66B | Mid cap | +233.88% |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% |
| OPCH | Option Care Health, Inc. | $3.60B | Mid cap | −15.91% |
| A2LC34.SA | Alcon Inc. | $3.57B | Mid cap | −12.15% |
| VCYT | Veracyte, Inc. Common Stock | $3.56B | Mid cap | +54.81% |
| GPCR | Structure Therapeutics Inc. | $3.56B | Mid cap | +159.74% |
| GRAL | GRAIL, Inc. | $3.55B | Mid cap | +136.66% |
| QURE | uniQure N.V. | $3.53B | Mid cap | +223.49% |
| NHC | National HealthCare Corporation | $3.53B | Mid cap | +103.83% |
| PLSE | Pulse Biosciences, Inc. | $3.43B | Mid cap | +203.47% |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +188.94% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.30B | Mid cap | +281.97% |
| NAMS | NewAmsterdam Pharma Company N.V. | $3.27B | Mid cap | +11.97% |
| MBX | MBX Biosciences, Inc. | $3.22B | Mid cap | +366.53% |
| BEAM | Beam Therapeutics Inc. | $3.21B | Mid cap | +79.06% |
| TMDX | TransMedics Group, Inc. | $3.19B | Mid cap | −21.43% |
| CLDX | Celldex Therapeutics, Inc. | $3.19B | Mid cap | +79.51% |
| IRON | Disc Medicine, Inc. | $3.17B | Mid cap | +37.90% |
| WRBY | Warby Parker Inc. | $3.15B | Mid cap | −3.96% |
| ARQT | Arcutis Biotherapeutics, Inc. | $3.12B | Mid cap | +60.64% |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.10B | Mid cap | +22.19% |
| ALMS | Alumis Inc. | $3.06B | Mid cap | +380.08% |
| HYPE3.SA | Hypera S.A. | $2.98B | Mid cap | −4.69% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% |
| ZLAB | Zai Lab Limited | $2.92B | Mid cap | −20.06% |
| BKD | Brookdale Senior Living Inc. | $2.91B | Mid cap | +55.61% |
| ALHC | Alignment Healthcare, Inc. | $2.88B | Mid cap | −13.88% |
| ACHC | Acadia Healthcare Company, Inc. | $2.85B | Mid cap | +37.81% |
| SLS | SELLAS Life Sciences Group, Inc. | $2.77B | Mid cap | +615.10% |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% |
| VRDN | Viridian Therapeutics, Inc. | $2.75B | Mid cap | +30.71% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% |
| RGC | Regencell Bioscience Holdings Limited | $2.72B | Mid cap | −61.38% |
| PRVA | Privia Health Group, Inc. | $2.71B | Mid cap | −3.13% |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | −30.11% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +219.58% |
| VERA | Vera Therapeutics, Inc. | $2.65B | Mid cap | +67.21% |
| PGEN | Precigen, Inc. | $2.65B | Mid cap | +61.66% |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.61B | Mid cap | −0.42% |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.61B | Mid cap | −12.10% |
| PHVS | Pharvaris N.V. | $2.60B | Mid cap | +55.59% |
| BHVN | Biohaven Ltd. | $2.56B | Mid cap | +8.65% |
| TRVI | Trevi Therapeutics, Inc. | $2.55B | Mid cap | +124.00% |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% |
| NKTR | Nektar Therapeutics | $2.52B | Mid cap | +151.95% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.51B | Mid cap | +15.38% |
| CURA.TO | Curaleaf Holdings, Inc. | $2.51B | Mid cap | +197.74% |
| KOD | Kodiak Sciences Inc. | $2.48B | Mid cap | +321.09% |
| PBH | Prestige Consumer Healthcare Inc. | $2.47B | Mid cap | −22.12% |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% |
| NUVB | Nuvation Bio Inc. | $2.44B | Mid cap | +135.93% |
| BHC | Bausch Health Companies Inc. | $2.43B | Mid cap | −10.45% |
| BHC.TO | Bausch Health Companies Inc. | $2.43B | Mid cap | −9.88% |
| KLRA | Kailera Therapeutics, Inc. | $2.39B | Mid cap | −29.08% |
| OCUL | Ocular Therapeutix, Inc. | $2.37B | Mid cap | −12.58% |
| ALMR | Alamar Biosciences, Inc. | $2.36B | Mid cap | +54.91% |
| GRDN | Guardian Pharmacy Services, Inc. | $2.36B | Mid cap | +45.50% |
| UFPT | UFP Technologies, Inc. | $2.36B | Mid cap | +41.94% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% |
| BFLY | Butterfly Network, Inc. | $2.30B | Mid cap | +450.32% |
| COAG | Hemab Therapeutics Holdings, Inc. | $2.30B | Mid cap | +44.68% |
| MLYS | Mineralys Therapeutics, Inc. | $2.28B | Mid cap | +70.22% |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% |
| NBTX | Nanobiotix S.A. | $2.26B | Mid cap | +394.99% |
| CLOV | Clover Health Investments, Corp. | $2.26B | Mid cap | +57.99% |
| ADUS | Addus HomeCare Corporation | $2.25B | Mid cap | +4.50% |
| URGN | UroGen Pharma Ltd. | $2.25B | Mid cap | +135.11% |
| MESO | Mesoblast Limited | $2.23B | Mid cap | +4.47% |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.20B | Mid cap | +36.58% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +56.87% |
| XRAY | DENTSPLY SIRONA Inc. | $2.18B | Mid cap | −21.61% |
| EXE.TO | Extendicare Inc. | $2.18B | Mid cap | +146.56% |
| VCEL | Vericel Corporation | $2.17B | Mid cap | +18.25% |
| ADMA | ADMA Biologics, Inc. | $2.16B | Mid cap | −44.17% |
| ZBIO | Zenas BioPharma, Inc. | $2.15B | Mid cap | +97.73% |
| ESTA | Establishment Labs Holdings Inc. | $2.15B | Mid cap | +70.71% |
| CLOV34.SA | Clover Health Investments, Corp. | $2.15B | Mid cap | +45.23% |
| HCM | HUTCHMED (China) Limited | $2.15B | Mid cap | −17.45% |
| STOK | Stoke Therapeutics, Inc. | $2.14B | Mid cap | +71.45% |
| XNCR | Xencor, Inc. Common Stock | $2.11B | Mid cap | +254.61% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% |
| NVCR | NovoCure Limited | $2.08B | Mid cap | +50.21% |
| GENB | Generate Biomedicines, Inc. | $2.07B | Mid cap | +27.59% |
| SRPT | Sarepta Therapeutics, Inc. | $2.06B | Mid cap | +7.69% |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | −36.05% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +28.14% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $2.03B | Mid cap | −13.45% |
| CMPS | COMPASS Pathways plc | $2.02B | Mid cap | +209.53% |
| GHRS | GH Research PLC | $1.99B | Small cap | +112.84% |
| PIII | P3 Health Partners Inc. | $1.98B | Small cap | +26.37% |
| PGNY | Progyny, Inc. | $1.98B | Small cap | +14.55% |
| S1RP34.SA | Sarepta Therapeutics, Inc. | $1.98B | Small cap | −12.20% |
| FLRY3.SA | Fleury S.A. | $1.97B | Small cap | +37.82% |
| TSHA | Taysha Gene Therapies, Inc. | $1.96B | Small cap | +102.69% |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +13.69% |
| ASTH | Astrana Health, Inc. | $1.92B | Small cap | +23.71% |
| LKFT | Lakefront Biotherapeutics NV | $1.91B | Small cap | −11.39% |
| SNDA | Sonida Senior Living, Inc. | $1.91B | Small cap | +51.53% |
| NTLA | Intellia Therapeutics, Inc. | $1.89B | Small cap | +15.50% |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +804.46% |
| SEPN | Septerna, Inc. | $1.88B | Small cap | +218.81% |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.87B | Small cap | −28.63% |
| SGRY | Surgery Partners, Inc. | $1.84B | Small cap | −38.48% |
| PSNL | Personalis, Inc. | $1.82B | Small cap | +257.32% |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.50% |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% |
| LMAT | LeMaitre Vascular, Inc. | $1.81B | Small cap | −16.20% |
| ETON | Eton Pharmaceuticals, Inc. | $1.79B | Small cap | +262.38% |
| INSP | Inspire Medical Systems, Inc. | $1.79B | Small cap | −33.04% |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +23.55% |
| FTRE | Fortrea Holdings Inc. | $1.76B | Small cap | +105.20% |
| ALVO | Alvotech | $1.75B | Small cap | −38.85% |
| ANAB | AnaptysBio, Inc. | $1.73B | Small cap | +326.47% |
| ANIP | ANI Pharmaceuticals, Inc. | $1.71B | Small cap | −18.85% |
| MAZE | Maze Therapeutics, Inc. | $1.69B | Small cap | +113.27% |
| SIA.TO | Sienna Senior Living Inc. | $1.65B | Small cap | +25.96% |
| AVLN | Avalyn Pharma Inc. | $1.64B | Small cap | +25.60% |
| BCAX | Bicara Therapeutics Inc. | $1.64B | Small cap | +105.74% |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% |
| AGL | agilon health, inc. | $1.61B | Small cap | +194.58% |
| ARDT | Ardent Health, Inc. | $1.58B | Small cap | −11.64% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.58B | Small cap | +8.64% |
| ABSI | Absci Corporation | $1.58B | Small cap | +261.57% |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.58B | Small cap | +132.58% |
| AAPG | Ascentage Pharma Group Internat | $1.58B | Small cap | −59.18% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | $1.58B | Small cap | +298.89% |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +47.05% |
| TYRA | Tyra Biosciences, Inc. | $1.56B | Small cap | +103.57% |
| KMTS | Kestra Medical Technologies, Ltd. | $1.56B | Small cap | +47.61% |
| LBRX | LB Pharmaceuticals Inc | $1.55B | Small cap | +178.41% |
| AVBP | ArriVent BioPharma, Inc. | $1.54B | Small cap | +62.10% |
| CNMD | CONMED Corporation | $1.53B | Small cap | −6.91% |
| INVA | Innoviva, Inc. | $1.53B | Small cap | +7.06% |
| OMCL | Omnicell, Inc. | $1.53B | Small cap | +0.66% |
| NVAX | Novavax, Inc. | $1.52B | Small cap | +21.50% |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% |
| SPTX | Seaport Therapeutics, Inc. | $1.49B | Small cap | +40.32% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $1.49B | Small cap | +74.45% |
| INNV | InnovAge Holding Corp. | $1.48B | Small cap | +178.79% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% |
| AKTS | Aktis Oncology, Inc. | $1.47B | Small cap | +18.35% |
| AZTA | Azenta, Inc. | $1.47B | Small cap | +11.16% |
| OMDA | Omada Health, Inc. | $1.47B | Small cap | +2.74% |
| PAHC | Phibro Animal Health Corporation | $1.46B | Small cap | +13.01% |
| SDGR | Schrödinger, Inc. | $1.46B | Small cap | −1.62% |
| ENOV | Enovis Corporation | $1.46B | Small cap | −18.60% |
| ATEC | Alphatec Holdings, Inc. | $1.45B | Small cap | −41.78% |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.44B | Small cap | +35.58% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $1.43B | Small cap | +786.65% |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +100.54% |
| IMTX | Immatics N.V. | $1.41B | Small cap | +74.63% |
| OMER | Omeros Corporation | $1.40B | Small cap | +328.71% |
| JBIO | Jade Biosciences, Inc. | $1.39B | Small cap | +168.30% |
| DRTS | Alpha Tau Medical Ltd. | $1.38B | Small cap | +343.92% |
| P1RG34.SA | Perrigo Company plc | $1.37B | Small cap | −59.77% |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% |
| PNTG | The Pennant Group, Inc. | $1.34B | Small cap | +56.31% |
| AORT | Artivion, Inc. | $1.33B | Small cap | −37.81% |
| AMN | AMN Healthcare Services, Inc. | $1.33B | Small cap | +70.26% |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.82% |
| MNKD | MannKind Corporation | $1.32B | Small cap | −9.51% |
| CRON.TO | Cronos Group Inc. | $1.31B | Small cap | +39.83% |
| CRON | Cronos Group Inc. | $1.31B | Small cap | +38.67% |
| IART | Integra LifeSciences Holdings Corporation | $1.31B | Small cap | +13.52% |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −40.82% |
| SANA | Sana Biotechnology, Inc. | $1.25B | Small cap | +23.44% |
| GDRX | GoodRx Holdings, Inc. | $1.25B | Small cap | −18.89% |
| CERT | Certara, Inc. | $1.24B | Small cap | −25.07% |
| ODTX | Odyssey Therapeutics, Inc. | $1.23B | Small cap | +56.03% |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.23B | Small cap | +207.92% |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.82% |
| PRCT | PROCEPT BioRobotics Corporation | $1.21B | Small cap | −48.36% |
| AVNS | Avanos Medical Inc | $1.17B | Small cap | +110.53% |
| USPH | U.S. Physical Therapy, Inc. | $1.17B | Small cap | −5.67% |
| KURA | Kura Oncology, Inc. | $1.16B | Small cap | +66.16% |
| JANX | Janux Therapeutics, Inc. | $1.15B | Small cap | −19.10% |
| TDOC | Teladoc Health, Inc. | $1.15B | Small cap | −18.22% |
| SVRA | Savara Inc. | $1.15B | Small cap | +70.52% |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.15B | Small cap | −35.42% |
| STAA | STAAR Surgical Company | $1.15B | Small cap | −16.90% |
| IVA | Inventiva S.A. | $1.14B | Small cap | −7.84% |
| T2DH34.SA | Teladoc Health, Inc. | $1.13B | Small cap | −24.67% |
| IRMD | IRADIMED CORPORATION | $1.12B | Small cap | +19.80% |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +6.34% |
| AVTX | Avalo Therapeutics, Inc. | $1.10B | Small cap | +112.95% |
| J2AZ34.SA | Jazz Pharmaceuticals plc | $1.08B | Small cap | +35.66% |
| SLDB | Solid Biosciences Inc. | $1.04B | Small cap | +72.95% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $1.04B | Small cap | +104.42% |
| CSTL | Castle Biosciences, Inc. | $1.04B | Small cap | +52.96% |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −48.12% |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +42.19% |
| QDEL | QuidelOrtho Corporation | $1.02B | Small cap | −46.31% |
| PCRX | Pacira BioSciences, Inc. | $1.02B | Small cap | −0.88% |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% |
| IMMX | Immix Biopharma, Inc. | $1.00B | Small cap | +617.86% |
| GERN | Geron Corporation | $995.83M | Small cap | +8.51% |
| HELP | Cybin D/B/A Helus Pharma | $995.81M | Small cap | +77.71% |
| ARDX | Ardelyx, Inc. | $975.95M | Small cap | −38.13% |
| DSGN | Design Therapeutics, Inc. | $975.65M | Small cap | +194.71% |
| BVS | Bioventus Inc. | $954.22M | Small cap | +86.52% |
| OLMA | Olema Pharmaceuticals, Inc. | $949.35M | Small cap | +89.02% |
| ANNX | Annexon, Inc. | $946.00M | Small cap | +136.49% |
| DBVT | DBV Technologies S.A. | $940.80M | Small cap | +53.00% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $934.98M | Small cap | −27.78% |
| CLYM | Climb Bio Inc | $923.57M | Small cap | +603.72% |
| ACRS | Aclaris Therapeutics, Inc. | $911.16M | Small cap | +240.11% |
| B2RK34.SA | Bruker Corporation | $906.52M | Small cap | +63.27% |
| CBLL | CeriBell, Inc. | $899.97M | Small cap | +102.16% |
| SGP | SpyGlass Pharma, Inc. | $891.05M | Small cap | +0.91% |
| ANL | Adlai Nortye Ltd. | $884.83M | Small cap | +791.12% |
| TBPH | Theravance Biopharma, Inc. | $884.18M | Small cap | +23.41% |
| TALK | Talkspace, Inc. | $870.57M | Small cap | +93.73% |
| BBNX | Beta Bionics, Inc. | $870.10M | Small cap | +1.95% |
| AVR | Anteris Technologies Global Corp. | $865.37M | Small cap | +144.54% |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +16.99% |
| INMD | InMode Ltd. | $864.89M | Small cap | −1.71% |
| SIBN | SI-BONE, Inc. | $861.71M | Small cap | +17.12% |
| FDMT | 4D Molecular Therapeutics, Inc. | $859.60M | Small cap | +140.87% |
| COLL | Collegium Pharmaceutical, Inc. | $852.79M | Small cap | −29.08% |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% |
| AHG | Akso Health Group | $848.14M | Small cap | −43.10% |
| PHAR | Pharming Group N.V. | $845.80M | Small cap | −14.47% |
| SLN | Silence Therapeutics plc | $840.94M | Small cap | +160.19% |
| HSTM | HealthStream, Inc. | $840.94M | Small cap | +1.86% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | $819.46M | Small cap | +45.87% |
| NVCT | Nuvectis Pharma, Inc. | $816.10M | Small cap | +275.94% |
| WELL.TO | WELL Health Technologies Corp. | $807.72M | Small cap | −8.18% |
| AURA | Aura Biosciences, Inc. | $801.64M | Small cap | +20.03% |
| STTK | Shattuck Labs, Inc. | $792.87M | Small cap | +690.00% |
| VREX | Varex Imaging Corporation | $778.90M | Small cap | +61.40% |
| AHCO | AdaptHealth Corp. | $771.43M | Small cap | −38.44% |
| NGNE | Neurogene Inc. | $768.64M | Small cap | +95.02% |
| MNPR | Monopar Therapeutics Inc. | $763.31M | Small cap | +226.69% |
| DRUG | Bright Minds Biosciences Inc. | $751.90M | Small cap | +76.73% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $751.23M | Small cap | −0.43% |
| D2OC34.SA | Doximity, Inc. | $733.94M | Small cap | −65.76% |
| SOPH | SOPHiA GENETICS SA | $726.14M | Small cap | +156.16% |
| CTMX | CytomX Therapeutics, Inc. | $723.43M | Small cap | +60.39% |
| ASMB | Assembly Biosciences, Inc. | $721.17M | Small cap | +36.81% |
| OCS | Oculis Holding AG | $720.20M | Small cap | −25.14% |
| PHR | Phreesia, Inc. | $716.58M | Small cap | −63.74% |
| SSII | SS Innovations International, Inc. | $715.38M | Small cap | −50.55% |
| DHT-UN.TO | DRI Healthcare Trust | $714.70M | Small cap | +27.29% |
| XOMA | XOMA Royalty Corp | $710.16M | Small cap | +19.27% |
| PHAT | Phathom Pharmaceuticals, Inc. | $709.50M | Small cap | −29.50% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $708.88M | Small cap | +240.48% |
| GYRE | Gyre Therapeutics, Inc. | $705.12M | Small cap | −18.00% |
| ALLO | Allogene Therapeutics, Inc. | $704.80M | Small cap | +75.86% |
| C2RS34.SA | CRISPR Therapeutics AG | $704.10M | Small cap | +0.85% |
| AGMB | AgomAb Therapeutics NV | $703.26M | Small cap | −2.53% |
| TECX | Tectonic Therapeutic, Inc. | $703.19M | Small cap | +35.43% |
| OABI | OmniAb, Inc. | $699.33M | Small cap | +198.76% |
| ZVRA | Zevra Therapeutics, Inc. | $697.17M | Small cap | +25.43% |
| BHVN34.SA | BIOHAVEN LTDDRN | $694.68M | Small cap | −18.03% |
| PROK | ProKidney Corp. | $694.58M | Small cap | −30.12% |
| EVO | Evotec SE | $693.01M | Small cap | −44.13% |
| GMRS | GMR Solutions Inc. | $692.56M | Small cap | −8.30% |
| GUD.TO | Knight Therapeutics Inc. | $690.78M | Small cap | +50.39% |
| DHT-U.TO | DRI Healthcare Trust | $690.34M | Small cap | +27.68% |
| EIKN | Eikon Therapeutics, Inc. | $679.77M | Small cap | −20.13% |
| AQST | Aquestive Therapeutics, Inc. | $676.51M | Small cap | +40.00% |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% |
| CBIO | Crescent Biopharma, Inc. | $669.39M | Small cap | +26.46% |
| CRMD | CorMedix Inc. | $653.95M | Small cap | −40.66% |
| PRME | Prime Medicine, Inc. | $649.33M | Small cap | +4.37% |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% |
| MDXG | MiMedx Group, Inc. | $644.26M | Small cap | −38.35% |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −20.45% |
| TLRY.TO | Tilray Brands, Inc. | $640.36M | Small cap | +240.00% |
| CTNM | Contineum Therapeutics, Inc. | $640.31M | Small cap | +70.03% |
| KIDS | OrthoPediatrics Corp. | $639.69M | Small cap | +11.10% |
| TLRY | Tilray Brands, Inc. | $638.38M | Small cap | −66.13% |
| CTEV | Claritev Corporation | $636.72M | Small cap | −47.71% |
| VALN | Valneva SE | $634.84M | Small cap | −23.49% |
| DASA3.SA | Diagnósticos da América S.A. | $633.57M | Small cap | +93.33% |
| ICLR34.SA | ICON PLC DRN | $625.18M | Small cap | −14.33% |
| AUTL | Autolus Therapeutics plc | $620.16M | Small cap | +48.41% |
| ARVN | Arvinas, Inc. | $609.40M | Small cap | +15.35% |
| ALT | Altimmune, Inc. | $604.95M | Small cap | −14.17% |
| MPLT | MapLight Therapeutics, Inc. | $596.42M | Small cap | −29.88% |
| CTKB | Cytek Biosciences, Inc. | $594.02M | Small cap | +11.74% |
| RGNX | REGENXBIO Inc. | $588.18M | Small cap | +6.35% |
| WEAV | Weave Communications, Inc. | $584.79M | Small cap | −5.68% |
| EOLS | Evolus, Inc. | $579.92M | Small cap | +15.83% |
| ARTV | Artiva Biotherapeutics, Inc. | $575.44M | Small cap | +259.94% |
| BWAY | BrainsWay Ltd. | $574.70M | Small cap | +87.42% |
| ZURA | Zura Bio Limited | $574.02M | Small cap | +177.31% |
| DCTH | Delcath Systems, Inc. | $569.06M | Small cap | +49.91% |
| SPRY | ARS Pharmaceuticals, Inc. | $568.84M | Small cap | −55.13% |
| OVID | Ovid Therapeutics Inc. | $562.46M | Small cap | +128.57% |
| EVH | Evolent Health, Inc. | $556.25M | Small cap | −48.86% |
| ENTX | Entera Bio Ltd. | $552.32M | Small cap | +62.76% |
| CERS | Cerus Corporation | $552.18M | Small cap | +109.16% |
| KYTX | Kyverna Therapeutics, Inc. | $546.70M | Small cap | +133.33% |
| CABA | Cabaletta Bio, Inc. | $545.94M | Small cap | +116.67% |
| FLGT | Fulgent Genetics, Inc. | $545.08M | Small cap | −8.46% |
| SRTA | Strata Critical Medical, Inc. | $541.42M | Small cap | +33.62% |
| TCMD | Tactile Systems Technology, Inc. | $532.56M | Small cap | +78.78% |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% |
| CCCC | C4 Therapeutics, Inc. | $521.63M | Small cap | +64.34% |
| TOI | Starling Oncology Inc | $512.91M | Small cap | +79.19% |
| DNA | Ginkgo Bioworks Holdings, Inc. | $507.75M | Small cap | −41.46% |
| NPCE | NeuroPace, Inc. | $503.88M | Small cap | +65.32% |
| EVMN | Evommune, Inc. | $500.47M | Small cap | −30.25% |
| CLPT | ClearPoint Neuro, Inc. | $499.35M | Small cap | +53.85% |
| SENS | Senseonics Holdings, Inc. | $493.84M | Small cap | +0.43% |
| CGC | Canopy Growth Corporation | $492.21M | Small cap | −31.46% |
| EPRX | Eupraxia Pharmaceuticals Inc. | $490.26M | Small cap | +40.72% |
| WEED.TO | Canopy Growth Corporation | $489.98M | Small cap | −31.25% |
| EDIT | Editas Medicine, Inc. | $488.38M | Small cap | +19.10% |
| EPRX.TO | Eupraxia Pharmaceuticals Inc. | $487.17M | Small cap | +43.78% |
| NRC | NRC Health | $487.06M | Small cap | +45.92% |
| RLMD | Relmada Therapeutics, Inc. | $485.35M | Small cap | +579.10% |
| RZLT | Rezolute, Inc. | $485.31M | Small cap | −30.00% |
| PACB | Pacific Biosciences of California, Inc. | $484.90M | Small cap | +17.29% |
| KMDA | Kamada Ltd. Ordinary Shares | $483.48M | Small cap | +21.09% |
| CAPR | Capricor Therapeutics, Inc. | $481.97M | Small cap | +49.76% |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | $481.69M | Small cap | −1.57% |
| QTTB | Q32 Bio Inc. | $481.67M | Small cap | +840.70% |
| OCGN | Ocugen, Inc. | $478.15M | Small cap | +35.58% |
| PRTA | Prothena Corporation plc | $474.87M | Small cap | +8.06% |
| PBYI | Puma Biotechnology, Inc. | $472.84M | Small cap | +79.61% |
| SGHT | Sight Sciences, Inc. | $458.33M | Small cap | +97.87% |
| KSI.TO | kneat.com, inc. | $452.27M | Small cap | +19.93% |
| BIOA | BioAge Labs, Inc. | $451.63M | Small cap | +107.59% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $449.94M | Small cap | −8.44% |
| MCTA | Charming Medical Limited | $445.55M | Small cap | +319.36% |
| BNTC | Benitec Biopharma Inc. | $442.48M | Small cap | +0.16% |
| AVIR | Atea Pharmaceuticals, Inc. | $441.93M | Small cap | +53.06% |
| CARL | Carlsmed, Inc. | $441.76M | Small cap | +16.40% |
| CMPX | Compass Therapeutics, Inc. | $437.61M | Small cap | −25.91% |
| LRMR | Larimar Therapeutics, Inc. | $432.15M | Small cap | +6.92% |
| EYPT | EyePoint, Inc. | $430.20M | Small cap | −57.85% |
| FRX.TO | Fennec Pharmaceuticals Inc. | $429.52M | Small cap | +36.00% |
| MASS | 908 Devices Inc. | $428.63M | Small cap | +64.60% |
| CCRN | Cross Country Healthcare Inc | $428.06M | Small cap | +0.38% |
| FENC | Fennec Pharmaceuticals Inc. | $426.77M | Small cap | +34.62% |
| LXEO | Lexeo Therapeutics, Inc. | $420.90M | Small cap | +3.30% |
| GALT | Galectin Therapeutics Inc. | $418.53M | Small cap | +4.27% |
| XFOR | X4 Pharmaceuticals, Inc. | $412.45M | Small cap | −1.42% |
| ENTA | Enanta Pharmaceuticals, Inc. | $412.12M | Small cap | +65.89% |
| BLAU3.SA | Blau Farmacêutica S.A. | $406.91M | Small cap | −2.28% |
| RCKT | Rocket Pharmaceuticals, Inc. | $401.78M | Small cap | +10.24% |
| FHTX | Foghorn Therapeutics Inc. | $397.29M | Small cap | +23.66% |
| OFIX | Orthofix Medical Inc. | $397.14M | Small cap | −34.30% |
| TBRG | TruBridge Inc | $393.58M | Small cap | +30.42% |
| IPSC | Century Therapeutics, Inc. | $392.93M | Small cap | +315.53% |
| UPB | Upstream Bio, Inc. | $390.52M | Small cap | −57.31% |
| TKNO | Alpha Teknova, Inc. | $387.63M | Small cap | +62.25% |
| E2NO34.SA | Enovis Corporation | $387.44M | Small cap | −19.24% |
| MOBI | Mobia Medical, Inc. | $387.35M | Small cap | −0.85% |
| AUNA | Auna SA | $387.31M | Small cap | −16.85% |
| ONCO3.SA | Oncoclínicas do Brasil Serviços Médicos S.A. | $381.80M | Small cap | −33.79% |
| SLP | Simulations Plus, Inc. | $372.34M | Small cap | +28.20% |
| AGEN | Agenus Inc. | $371.33M | Small cap | +81.72% |
| PALI | Palisade Bio, Inc. | $371.20M | Small cap | +222.73% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $368.27M | Small cap | +113.74% |
| VHI.TO | Vitalhub Corp. | $364.45M | Small cap | −36.39% |
| LYEL | Lyell Immunopharma, Inc. | $362.68M | Small cap | +37.32% |
| DMAC | DiaMedica Therapeutics Inc. | $361.30M | Small cap | +12.04% |
| CATX | Perspective Therapeutics, Inc. | $360.72M | Small cap | −12.47% |
| IFRX | InflaRx N.V. | $356.63M | Small cap | +142.00% |
| STRO | Sutro Biopharma, Inc. | $355.50M | Small cap | +138.11% |
| VMD | Viemed Healthcare, Inc. | $355.36M | Small cap | +29.94% |
| SABS | SAB Biotherapeutics, Inc. | $353.03M | Small cap | +83.02% |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | $350.76M | Small cap | +20.56% |
| IKT | Inhibikase Therapeutics, Inc. | $347.44M | Small cap | +39.11% |
| CLLS | Cellectis S.A. | $344.40M | Small cap | +28.09% |
| ABEO | Abeona Therapeutics Inc. | $343.68M | Small cap | −12.90% |
| NNNN | Anbio Biotechnology | $343.67M | Small cap | −83.55% |
| IMRX | Immuneering Corporation | $333.19M | Small cap | −0.77% |
| P2OD34.SA | Insulet Corporation | $332.45M | Small cap | −26.20% |
| PRQR | ProQR Therapeutics N.V. | $331.63M | Small cap | +6.33% |
| RCEL | AVITA Medical, Inc. | $327.52M | Small cap | +133.77% |
| VNDA | Vanda Pharmaceuticals Inc. | $323.48M | Small cap | +15.80% |
| MATD3.SA | Hospital Mater Dei S.A. | $321.33M | Small cap | +11.78% |
| SMTI | Sanara MedTech Inc. | $318.55M | Small cap | +2.09% |
| OBIO | Orchestra BioMed Holdings, Inc. | $316.15M | Small cap | +85.21% |
| IRD | Opus Genetics, Inc. | $316.14M | Small cap | +216.67% |
| RNAC | Cartesian Therapeutics, Inc. | $308.30M | Small cap | −4.09% |
| YDES | YD Bio Ltd | $307.41M | Small cap | −63.83% |
| TMCI | Treace Medical Concepts, Inc. | $306.96M | Small cap | −36.39% |
| EBS | Emergent BioSolutions Inc. | $306.10M | Small cap | −30.50% |
| FATE | Fate Therapeutics, Inc. Common Stock | $305.54M | Small cap | +129.46% |
| BCYC | Bicycle Therapeutics plc | $304.03M | Small cap | −37.79% |
| TLSI | TriSalus Life Sciences, Inc. | $303.56M | Small cap | −3.33% |
| AMRN | Amarin Corporation plc | $301.43M | Small cap | −7.08% |
| AVXL | Anavex Life Sciences Corp. | $300.34M | Small cap | −65.71% |
| MYGN | Myriad Genetics, Inc. | $298.43M | Small cap | −47.39% |
| TRDA | Entrada Therapeutics, Inc. | $296.70M | Small cap | +23.24% |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +225.53% |
| FULC | Fulcrum Therapeutics, Inc. | $294.51M | Small cap | −41.78% |
| NMRA | Neumora Therapeutics, Inc. | $293.12M | Small cap | −11.36% |
| TTRX | Turn Therapeutics Inc. | $292.44M | Small cap | +37.57% |
| CV | CapsoVision, Inc. | $291.27M | Small cap | +46.97% |
| ANIK | Anika Therapeutics, Inc. | $290.14M | Small cap | +136.17% |
| EDT.TO | Spectral Medical Inc. | $286.47M | Small cap | −6.99% |
| EMBC | Embecta Corp. | $285.00M | Small cap | −64.70% |
| LCTX | Lineage Cell Therapeutics, Inc. | $283.26M | Small cap | −8.20% |
| SION | Sionna Therapeutics, Inc. | $282.58M | Small cap | −75.45% |
| PYXS | Pyxis Oncology, Inc. | $278.58M | Small cap | +145.59% |
| WHWK | Whitehawk Therapeutics, Inc. | $275.92M | Small cap | +167.40% |
| SRZN | Surrozen, Inc. | $274.56M | Small cap | +107.98% |
| ALXO | ALX Oncology Holdings Inc. | $273.79M | Small cap | +65.00% |
| ELDN | Eledon Pharmaceuticals, Inc. | $272.22M | Small cap | +29.84% |
| CGEN | Compugen Ltd. | $271.86M | Small cap | +93.20% |
| GLSI | Greenwich LifeSciences, Inc. | $267.58M | Small cap | +56.21% |
| ELMD | Electromed, Inc. | $265.79M | Small cap | +28.26% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.